MAIA Biotechnology Inc (MAIA)’s latest quarter sales figures and margins explained

MAIA Biotechnology Inc [MAIA] stock is trading at $2.48, up 12.73%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MAIA shares have gain 17.54% over the last week, with a monthly amount glided 89.31%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

On 28, March 2024, MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero. In a post published today on Yahoo Finance, Company recognizes significant support by board members in recent private placement.

From an analyst’s perspective:

MAIA Biotechnology Inc [MAIA] stock has fluctuated between $0.82 and $4.25 over the past year. MAIA Biotechnology Inc [AMEX: MAIA] shares were valued at $2.48 at the most recent close of the market.

Analyzing the MAIA fundamentals

To continue investigating profitability, this company’s Return on Assets is posted at -2.51, Equity is -3.03 and Total Capital is -6.7.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.26 points at the first support level, and at 2.04 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.62, and for the 2nd resistance point, it is at 2.75.

MAIA Biotechnology Inc [MAIA] reported earnings per share of -$0.4 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.39/share, meaning a difference of -$0.01 and a surprise factor of -2.60%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.36 per share as compared to estimates of -$0.38 per share, a difference of $0.02 representing a surprise of 5.30%.

Ratios To Look Out For

For context, MAIA Biotechnology Inc’s Current Ratio is 1.53. In addition, the Quick Ratio stands at 1.53 and the Cash Ratio stands at 1.47.

Transactions by insiders

Recent insider trading involved Smith Stan, Director, that happened on Mar 14 ’24 when 0.17 million shares were purchased. Director, Louie Ngar Yee completed a deal on Mar 14 ’24 to buy 0.17 million shares. Meanwhile, Director Luput Cristian bought 69282.0 shares on Mar 14 ’24.

Related Posts